G7 countries expected to donate 1 billion COVID-19 vaccine doses worldwide


On the eve of the Group of Seven summit in England, British Prime Minister Boris Johnson on Thursday night announced that the G7 nations are expected to pledge at least 1 billion COVID-19 vaccine doses to distribute globally.
Earlier, President Biden said that on Friday, the G7 countries — the United States, the United Kingdom, Canada, Japan, France, Germany, and Italy — will share more details on their vaccine donation commitments. The U.S. will donate 500 million doses on top of 80 million doses already pledged, Biden said, adding, "We're going to help lead the world out of this pandemic working alongside our global partners."
The U.S. doses will be manufactured by Pfizer, and will be distributed beginning in August through the COVAX alliance to 92 lower-income countries and the African Union, The Associated Press reports. "Our vaccine donations don't include pressure for favors or potential concessions," Biden said. "We're doing this to save lives, to end this pandemic, that's it. Our values call on us to do everything that we can to vaccinate the world against COVID-19."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The United Kingdom is committed to delivering 100 million vaccine doses, AP says, with the first 5 million going out in the next few weeks. French President Emmanuel Macron on Thursday said his country will share at least 30 million doses by the end of the year, and he believes "the European Union needs to have at least the same level of ambition as the United States. It's almost more important to say how many [doses] we deliver the next month than making promises to be fulfilled in 18 months from now."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
Why is a new Air Force One taking so long to build?
The Explainer Trump may look for alternatives for his new plane
By Joel Mathis, The Week US Published
-
New and notable podcasts for March
Feature The MeidasTouch Podcast and The Magnificent Others With Billy Corgan
By The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published